Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

19. Juni 2017 08:00 ET | Quelle: Ammonett Pharma LLC

Ammonett Pharma Granted Orphan Drug Designation From the U.S. FDA for Ibutamoren Mesylate (MK-0677) for Treatment of Growth Hormone Deficiency

MIDLOTHIAN, Va., June 19, 2017 (GLOBE NEWSWIRE) -- Ammonett Pharma LLC (the Company or Ammonett), a privately-held biotechnology company developing a novel, daily, orally-administered mini-pill...
25. Mai 2017 08:00 ET | Quelle: Ammonett Pharma LLC

Ammonett Pharma Receives Notice of Allowance of U.S. Patent for Oratrope™ Related to Detecting and Treating Growth Hormone Deficiency

MIDLOTHIAN, Va., May 25, 2017 (GLOBE NEWSWIRE) -- Ammonett Pharma LLC (the Company or Ammonett), a privately-held biotechnology company developing a novel, daily, orally-administered mini-pill...
23. Mai 2017 08:00 ET | Quelle: Ammonett Pharma LLC

Ammonett Pharma Receives Positive Opinion from European Orphan Medicinal Products Committee for MK-0677 for Treatment of Pediatric Growth Hormone Deficiency

MIDLOTHIAN, Va., May 23, 2017 (GLOBE NEWSWIRE) -- Ammonett Pharma LLC (the Company or Ammonett), a privately-held biotechnology company developing a novel, daily, orally-administered mini-pill...